EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation

Madlen Jentzsch iD, Lara Bischof, Dominic Brauer, Donata Backhaus, Jule Ussmann, Georg-Nikolaus Franke iD, Vladan Vucinic iD, Uwe Platzbecker iD, Sebastian Schwind iD

Cancers · 18.02.2023 · 15 (4) · 1312

DOI: 10.3390/cancers15041312 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 18.02.2023. Verfasst von Madlen Jentzsch und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University of Leipzig Medical Center, 04103 Leipzig, Germany. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zusammen gegen den Krebs e.V., University Leipzig, Deutsche Gesellschaft für Innere Medizin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the presence of FLT3-ITD, as well as levels of the FLT3-ITD allelic ratio, have been described as prognostic factors in acute myeloid leukemia (AML), little is known about how the FLT3-ITD allelic ratio impacts patients’ outcomes when receiving an allogeneic hematopoietic stem cell transplantation (HSCT). We analyzed 118 patients (median age at diagnosis 58.3, range 14.3–82.3 years) harboring FLT3-ITD, of whom 94 patients were consolidated with an allogeneic HSCT and included in outcome analyses. A high FLT3-ITD allelic ratio was associated with a higher white blood cell count, higher blood and bone marrow blasts, and worse ELN2017 risk at diagnosis. Patients with a high FLT3-ITD allelic ratio more often had NPM1 mutations, while patients with a low allelic ratio more often had FLT3-TKD mutations. Patients with a high FLT3-ITD allelic ratio were less likely to achieve a measurable residual disease (MRD)-negative remission prior to allogeneic HSCT and had a trend for a shorter time to relapse. However, there was no distinct cumulative incidence of relapse, non-relapse mortality, or overall survival according to the FLT3-ITD allelic ratio in transplanted patients. While co-mutated FLT3-TKD was associated with better outcomes, the MRD status at HSCT was the most significant factor for outcomes. While our data indicates that an allogeneic HSCT may mitigate the adverse effect of a high FLT3-ITD allelic ratio, comparative studies are needed to evaluate which FLT3-ITD mutated patients benefit from which consolidation strategy.

Schlagwörter

Stichwörter der Autor:innen

FLT3acute myeloid leukemiaallelic ratiohematopoietic stem cell transplantationprognosis

Autor:innen und Institutionen

  • Medical Clinic and Policlinic 1, Hematology, Cellular Therapy and Hemostaseology, University of Leipzig Medical Center, 04103 Leipzig, Germany.

ORCID-Profile: Madlen Jentzsch, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind

Förderung

  • Zusammen gegen den Krebs e.V.
  • University Leipzig
  • Deutsche Gesellschaft für Innere Medizin
  • Deutsche José Carreras Leukämie-Stiftung
  • Verein Zusammen gegen den Krebs e.V.
  • Deutsche Jose-Carreras-Stiftung
  • University of Leipzig

Zitieren

APA

Jentzsch, M., Bischof, L., Brauer, D., Backhaus, D., Ussmann, J., Franke, G. N., Vucinic, V., Platzbecker, U., & Schwind, S. (2023). Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation. Cancers, 15(4), 1312. https://doi.org/10.3390/cancers15041312

Vancouver

Jentzsch M, Bischof L, Brauer D, Backhaus D, Ussmann J, Franke GN, et al. Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation. Cancers. 2023;15(4):1312. doi:10.3390/cancers15041312

BibTeX
@article{Jentzsch2023,
  author = {Jentzsch, Madlen and Bischof, Lara and Brauer, Dominic and Backhaus, Donata and Ussmann, Jule and Franke, Georg-Nikolaus and Vucinic, Vladan and Platzbecker, Uwe and Schwind, Sebastian},
  title = {Clinical Implications of the FLT3-ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {4},
  pages = {1312},
  doi = {10.3390/cancers15041312}
}
Kostenlos starten →